Who Should Consider Semaglutide Treatment
As an NAD+ precursor, niacinamide supports the function of sirtuins, enzymes involved in metabolic regulation, inflammation control, and longevity pathways
Realistic Weight Loss Goals One of the most important parts of any medical weight loss journey is setting realistic expectations
Assessments Baseline clinical and treatment characteristics including age, Eastern Cooperative Oncology Group Performance Status, comorbidities, use of antithrombotic medication, initial prostate-specific antigen (PSA) level, stage of prostate cancer, Gleason score, radiotherapy volume, treatment modality, use of androgen deprivation therapy, and dose-volume histogram (DVH) parameters of the rectal wall were collected
The deeper I dug, the clearer the picture became
Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment